<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>All Results for : "in vivo gene editing" OR "in vivo genome editing"</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9 mediated somatic recombination</h4><p><a href="https://www.biorxiv.org/content/10.1101/398347v1">Link</a></p><p><b>Date:</b> 2018-08-23</p><p><b>Authors:</b> Noboru Ideno ... Bidyut Ghosh</p><p><b>Downloads:</b> 1007</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Genetically engineered mouse models (GEMMs) that recapitulate the major genetic drivers in pancreatic ductal adenocarcinoma (PDAC) have provided unprecedented insights into the pathogenesis of this lethal neoplasm.  Nonetheless, generating an autochthonous model is an expensive , time consuming and labor intensive process, particularly when tissue specific expression or deletion of compound alleles are involved.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: CRISPR-mediated modeling and functional validation of candidate tumor suppressor genes in small cell lung cancer.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31871154">Link</a></p><p><b>Date:</b> 12/24/2019</p><p><b>Authors:</b> Sheng Rong Ng ...  Tyler Jacks</p><p><b>Journal:</b> Proc. Natl. Acad. Sci. U.S.A.</p><p><b>IF (7 or above):</b> 9.35</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Small cell lung cancer (SCLC) is a highly aggressive subtype of lung cancer that remains among the most lethal of solid tumor malignancies.  Recent genomic sequencing studies have identified many recurrently mutated genes in human SCLC tumors.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Comparative assessment of fluorescent proteins for in vivo imaging in an animal model system</h4><p><a href="https://www.biorxiv.org/content/10.1101/040279v1">Link</a></p><p><b>Date:</b> 2016-02-19</p><p><b>Authors:</b> Jennifer K Heppert ... B Goldstein</p><p><b>Downloads:</b> 4564</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Fluorescent protein tags are fundamental tools used to visualize gene products and analyze their dynamics in vivo.  Recent advances in genome editing have enabled precise insertion of fluorescent protein tags into the genomes of diverse organisms.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Organotypic brain slice cultures to model neurodegenerative proteinopathies.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31791377">Link</a></p><p><b>Date:</b> 12/03/2019</p><p><b>Authors:</b> C L Croft ...  T E Golde</p><p><b>Journal:</b> Mol Neurodegener</p><p><b>IF (7 or above):</b> 8.38</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Organotypic slice cultures of brain or spinal cord have been a longstanding tool in neuroscience research but their utility for understanding Alzheimer's disease (AD) and other neurodegenerative proteinopathies has only recently begun to be evaluated.  Organotypic brain slice cultures (BSCs) represe ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: New human chromosomal safe harbor sites for genome engineering with CRISPR/Cas9, TAL effector and homing endonucleases</h4><p><a href="https://www.biorxiv.org/content/10.1101/396390v1">Link</a></p><p><b>Date:</b> 2018-08-20</p><p><b>Authors:</b> Stefan Pellenz ... Raymond J Monnat</p><p><b>Downloads:</b> 3002</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Safe Harbor Sites (SHS) are genomic locations where new genes or genetic elements can be introduced without disrupting the expression or regulation of adjacent genes.  We have identified 35 potential new human SHS in order to substantially expand SHS options beyond the three widely used canonical human SHS, AAVS1, CCR5 and hROSA26.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31722192">Link</a></p><p><b>Date:</b> 11/13/2019</p><p><b>Authors:</b> Bianca Garcia ...  Alan R Davidson</p><p><b>Journal:</b> Cell Rep</p><p><b>IF (7 or above):</b> 7.70</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> CRISPR-Cas9 systems provide powerful tools for genome editing.  However, optimal employment of this technology will require control of Cas9 activity so that the timing, tissue specificity, and accuracy of editing may be precisely modulated.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: AAV-mediated CRISPR/Cas gene editing of retinal cells in vivo.</h4><p><a href="https://www.biorxiv.org/content/10.1101/039156v2">Link</a></p><p><b>Date:</b> 2016-02-09</p><p><b>Authors:</b> Sandy SC Hung ... Alex W. Hewitt</p><p><b>Downloads:</b> 1975</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> PURPOSE: CRISPR/Cas has recently been adapted to enable efficient editing of the mammalian genome, opening novel avenues for therapeutic intervention of inherited diseases.  In seeking to disrupt Yellow Fluorescent Protein (YFP) in a Thy1-YFP transgenic mouse, we assessed the feasibility of utilising the adeno-associated virus 2 (AAV2) to deliver CRISPR/Cas for genome modification of retinal cells in vivo.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Gene Therapy for Glaucoma by Ciliary Body Aquaporin 1 Disruption Using CRISPR-Cas9.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31981492">Link</a></p><p><b>Date:</b> 01/25/2020</p><p><b>Authors:</b> Jiahui Wu ...  Colin J Chu</p><p><b>Journal:</b> Mol. Ther.</p><p><b>IF (7 or above):</b> 7.47</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Glaucoma is a common cause of blindness, yet current therapeutic options are imperfect.  Clinical trials have invariably shown that reduction in intraocular pressure (IOP) regardless of disease subtype prevents visual loss.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Rapid discovery of synthetic DNA sequences to rewrite endogenous T cell circuits</h4><p><a href="https://www.biorxiv.org/content/10.1101/604561v1">Link</a></p><p><b>Date:</b> 2019-04-12</p><p><b>Authors:</b> Theodore L. Roth ... Alexander Marson</p><p><b>Downloads:</b> 1797</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Genetically-engineered immune cell therapies have been in development for decades and recently have proven effective to treat some types of cancer.  CRISPR-based genome editing methods, enabling more flexible and targeted sequence integrations than viral transduction, have the potential to extend the clinical utility of cell therapies.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Carboxylated branched poly(Î²-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31840076">Link</a></p><p><b>Date:</b> 12/16/2019</p><p><b>Authors:</b> Yuan Rui ...  Jordan J Green</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Efficient cytosolic protein delivery is necessary to fully realize the potential of protein therapeutics.  Current methods of protein delivery often suffer from low serum tolerance and limited in vivo efficacy.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Paired CRISPR/Cas9 guide-RNAs enable high-throughput deletion scanning (ScanDel) of a Mendelian disease locus for functionally critical non-coding elements</h4><p><a href="https://www.biorxiv.org/content/10.1101/092445v1">Link</a></p><p><b>Date:</b> 2016-12-08</p><p><b>Authors:</b> Molly Gasperini ... Jay Shendure</p><p><b>Downloads:</b> 1592</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The extent to which distal non-coding mutations contribute to Mendelian disease remains a major unknown in human genetics.  Given that a gene's in vivo function can be appropriately modeled in vitro, CRISPR/Cas9 genome editing enables the large-scale perturbation of distal non-coding regions to identify functional elements in their native context.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: A mutation-independent CRISPR-Cas9-mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32095520">Link</a></p><p><b>Date:</b> 02/25/2020</p><p><b>Authors:</b> Lili Wang ...  James M Wilson</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Ornithine transcarbamylase (OTC) deficiency is an X-linked urea cycle disorder associated with high mortality.  Although a promising treatment for late-onset OTC deficiency, adeno-associated virus (AAV) neonatal gene therapy would only provide short-term therapeutic effects as the non-integrated gen ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics</h4><p><a href="https://www.biorxiv.org/content/10.1101/588921v1">Link</a></p><p><b>Date:</b> 2019-03-26</p><p><b>Authors:</b> Christopher H Hulton ... John T Poirier</p><p><b>Downloads:</b> 1262</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Patient-derived xenografts (PDXs) constitute a powerful set of preclinical models for in vivo cancer research, reflecting the spectrum of genomic alterations and therapeutic liabilities of human cancers.  In contrast to either cancer cell lines or genetically engineered mouse models, the utility of PDXs has been limited by the inability to perform targeted genome editing of these tumors.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: CRISPR-Cas9-mediated therapeutic editing of </h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31692906">Link</a></p><p><b>Date:</b> 11/06/2019</p><p><b>Authors:</b> Dong Hyun Jo ...  Jung Min Lee</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Leber congenital amaurosis (LCA), one of the leading causes of childhood-onset blindness, is caused by autosomal recessive mutations in several genes including </p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Pooled AAV-CRISPR Screen with Targeted Amplicon Sequencing</h4><p><a href="https://www.biorxiv.org/content/10.1101/153643v1">Link</a></p><p><b>Date:</b> 2017-06-22</p><p><b>Authors:</b> Guangchuan Wang ... Sidi Chen</p><p><b>Downloads:</b> 1228</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> High-resolution, high-throughput direct in vivo screening of functional genetic factors in native tissues has long been challenging.  Adeno-associated viruses (AAV) are powerful carriers of transgenes and have been shown to mediate efficient genome editing in various organs in mice.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32128412">Link</a></p><p><b>Date:</b> 03/04/2020</p><p><b>Authors:</b> Yu Zhang ...  Eric N Olson</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Duchenne muscular dystrophy (DMD) is a lethal neuromuscular disease caused by mutations in the dystrophin gene (</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: BEHST: genomic set enrichment analysis enhanced through integration of chromatin long-range interactions</h4><p><a href="https://www.biorxiv.org/content/10.1101/168427v1">Link</a></p><p><b>Date:</b> 2019-01-15</p><p><b>Authors:</b> Davide Chicco ... Michael M. Hoffman</p><p><b>Downloads:</b> 1015</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Transforming data from genome-scale assays into knowledge of affected molecular functions and pathways is a key challenge in biomedical research.  Using vocabularies of functional terms and databases annotating genes with these terms, pathway enrichment methods can identify terms enriched in a gene list.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Curing hemophilia A by NHEJ-mediated ectopic F8 insertion in the mouse.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31843008">Link</a></p><p><b>Date:</b> 12/17/2019</p><p><b>Authors:</b> Jian-Ping Zhang ...  Xiao-Bing Zhang</p><p><b>Journal:</b> Genome Biol.</p><p><b>IF (7 or above):</b> 12.16</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> BACKGROUND: Hemophilia A, a bleeding disorder resulting from F8 mutations, can only be cured by gene therapy.  A promising strategy is CRISPR-Cas9-mediated precise insertion of F8 in hepatocytes at highly expressed gene loci, such as albumin (Alb).</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: CRISPR/Cas9-mediated gene deletion of the ompA gene in an Enterobacter gut symbiont impairs biofilm formation and reduces gut colonization of Aedes aegypti mosquitoes</h4><p><a href="https://www.biorxiv.org/content/10.1101/389957v3">Link</a></p><p><b>Date:</b> 2018-08-14</p><p><b>Authors:</b> Shivanand Hegde ... Grant L. Hughes</p><p><b>Downloads:</b> 980</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background: Symbiotic bacteria are pervasive in mosquitoes and their presence can influence many host phenotypes that affect vectoral capacity.  While it is evident that environmental and host genetic factors contribute in shaping the microbiome of mosquitoes, we have a poor understanding regarding how bacterial genetics affects colonization of the mosquito gut.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31811138">Link</a></p><p><b>Date:</b> 12/07/2019</p><p><b>Authors:</b> Hiroyuki Morisaka ...  Tomoji Mashimo</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.80</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Although single-component Class 2 CRISPR systems, such as type II Cas9 or type V Cas12a (Cpf1), are widely used for genome editing in eukaryotic cells, the application of multi-component Class 1 CRISPR has been less developed.  Here we demonstrate that type I-E CRISPR mediates distinct DNA cleavage  ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Somatic genome editing with the RCAS/TVA-CRISPR/Cas9 system for precision tumor modeling</h4><p><a href="https://www.biorxiv.org/content/10.1101/162669v1">Link</a></p><p><b>Date:</b> 2017-08-14</p><p><b>Authors:</b> Barbara Oldrini ... Massimo Squatrito</p><p><b>Downloads:</b> 746</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> It has been gradually established that the vast majority of human tumors are extraordinarily heterogeneous at a genetic level.  To accurately recapitulate this complexity, it is now evident that in vivo animal models of cancers will require to recreate not just a handful of simple genetic alterations, but possibly dozens and increasingly intricate.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Conditional control of RNA-guided nucleic acid cleavage and gene editing.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31900392">Link</a></p><p><b>Date:</b> 01/04/2020</p><p><b>Authors:</b> Shao-Ru Wang ...  Xiang Zhou</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.80</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Prokaryotes use repetitive genomic elements termed CRISPR (clustered regularly interspaced short palindromic repeats) to destroy invading genetic molecules.  Although CRISPR systems have been widely used in DNA and RNA technology, certain adverse effects do occur.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: CRISPR delivery particles for developing therapeutic strategies in metabolic disease</h4><p><a href="https://www.biorxiv.org/content/10.1101/352799v1">Link</a></p><p><b>Date:</b> 2018-06-21</p><p><b>Authors:</b> Yuefei Shen ... Michael P. Czech</p><p><b>Downloads:</b> 730</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> RNA-guided engineered nucleases derived from a prokaryotic adaptive immune system known as CRISPR-Cas represent a promising platform for gene deletion and editing.  As a therapeutic approach, direct delivery of Cas9 protein and guide RNA could circumvent the safety problems associated with plasmid delivery and therefore represents an attractive tool for genome engineering.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31980606">Link</a></p><p><b>Date:</b> 01/25/2020</p><p><b>Authors:</b> Koji M Nishiguchi ...  Toru Nakazawa</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.80</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Supplementing wildtype copies of functionally defective genes with adeno-associated virus (AAV) is a strategy being explored clinically for various retinal dystrophies.  However, the low cargo limit of this vector allows its use in only a fraction of patients with mutations in relatively small patho ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Identification of functional long non-coding RNAs in C. elegans</h4><p><a href="https://www.biorxiv.org/content/10.1101/383919v1">Link</a></p><p><b>Date:</b> 2018-08-02</p><p><b>Authors:</b> Alper Akay ... Wilfried Haerty</p><p><b>Downloads:</b> 594</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background: Functional characterisation of the compact genome of the model organism Caenorhabditis elegans remains incomplete despite its sequencing twenty years ago.  The last decade of research has seen a tremendous increase in the number of non-coding RNAs identified in various organisms.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: CRISPR-Switch regulates sgRNA activity by Cre recombination for sequential editing of two loci.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31784531">Link</a></p><p><b>Date:</b> 11/30/2019</p><p><b>Authors:</b> Krzysztof Chylinski ...  Ulrich Elling</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.80</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> CRISPR-Cas9 is an efficient and versatile tool for genome engineering in many species.  However, inducible CRISPR-Cas9 editing systems that regulate Cas9 activity or sgRNA expression often suffer from significant limitations, including reduced editing capacity, off-target effects, or leaky expressio ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: CRISPR/Cas9-mediated gene knockin in the hydroid Hydractinia symbiolongicarpus</h4><p><a href="https://www.biorxiv.org/content/10.1101/342592v1">Link</a></p><p><b>Date:</b> 2018-06-08</p><p><b>Authors:</b> Steven M. Sanders ... Matthew L Nicotra</p><p><b>Downloads:</b> 552</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background: Hydractinia symbiolongicarpus, a colonial cnidarian, is a tractable model system for many cnidarian-specific and general biological questions.  Until recently, tests of gene function in Hydractinia have relied on laborious forward genetic approaches, randomly integrated transgenes, or transient knockdown of mRNAs.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: MyoD induced enhancer RNA interacts with hnRNPL to activate target gene transcription during myogenic differentiation.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31857580">Link</a></p><p><b>Date:</b> 12/20/2019</p><p><b>Authors:</b> Yu Zhao ...  Huating Wang</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.80</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Emerging evidence supports roles of enhancer RNAs (eRNAs) in regulating target gene.  Here, we study eRNA regulation and function during skeletal myoblast differentiation.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Immunostimulatory guide RNAs mediate potent antiviral response</h4><p><a href="https://www.biorxiv.org/content/10.1101/282558v1">Link</a></p><p><b>Date:</b> 2018-03-15</p><p><b>Authors:</b> Yujia Cai ... SÃ¸ren Paludan</p><p><b>Downloads:</b> 506</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Genome-editing with CRISPR has emerged as a technology with broad therapeutic potential.  However, it is unclear whether CRISPR will elicit innate immune responses, which could impact both positively and negatively on the desired therapeutic effects.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticles.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31676764">Link</a></p><p><b>Date:</b> 11/04/2019</p><p><b>Authors:</b> Brian C Evans ...  Craig L Duvall</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.80</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Peptides and biologics provide unique opportunities to modulate intracellular targets not druggable by conventional small molecules.  Most peptides and biologics are fused with cationic uptake moieties or formulated into nanoparticles to facilitate delivery, but these systems typically lack potency  ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Drosophila CLAMP is an essential protein with sex-specific roles in males and females</h4><p><a href="https://www.biorxiv.org/content/10.1101/042820v1">Link</a></p><p><b>Date:</b> 2016-03-08</p><p><b>Authors:</b> Jennifer A. Urban ... Erica N. Larschan</p><p><b>Downloads:</b> 426</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Dosage compensation is a fundamental mechanism in many species that corrects for the inherent imbalance in X-chromosome copy number between XY males and XX females.  In Drosophila melanogaster, transcriptional output from the single male X-chromosome is equalized to that of XX females by recruitment of the Male Specific Lethal (MSL) complex to specific sequences along the length of the X-chromosome.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32005828">Link</a></p><p><b>Date:</b> 02/01/2020</p><p><b>Authors:</b> Marta Pradas-Juni ...  Jan-Wilhelm Kornfeld</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.80</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Obesity and type 2 diabetes mellitus are global emergencies and long noncoding RNAs (lncRNAs) are regulatory transcripts with elusive functions in metabolism.  Here we show that a high fraction of lncRNAs, but not protein-coding mRNAs, are repressed during diet-induced obesity (DIO) and refeeding, w ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Selective targeting of an oncogenic KRAS mutant allele by CRISPR/Cas9 induces efficient tumor regression</h4><p><a href="https://www.biorxiv.org/content/10.1101/807578v2">Link</a></p><p><b>Date:</b> 2019-10-17</p><p><b>Authors:</b> Qianqian Gao ... Cheng-chi Chao</p><p><b>Downloads:</b> 416</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background KRAS is one of the most frequently mutated oncogenes in human cancers, but its activating mutations have remained undruggable due to its picomolar affinity for GTP/GDP and its smooth protein structure resulting in the absence of known allosteric regulatory sites. 

Results With the goal of treating mutated KRAS -driven cancers, two CRISPR systems, CRISPR-SpCas9 genome-editing system and transcription-regulating system dCas9-KRAB, were developed to directly deplete KRAS mutant allele or to repress its transcription in cancer cells, respectively, through guide RNA specifically targeting the mutant but not wild-type allele.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: An intravital window to image the colon in real time.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31827103">Link</a></p><p><b>Date:</b> 12/12/2019</p><p><b>Authors:</b> Nikolai Rakhilin ...  Xiling Shen</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.80</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Intravital microscopy is a powerful technique to observe dynamic processes with single-cell resolution in live animals.  No intravital window has been developed for imaging the colon due to its anatomic location and motility, although the colon is a key organ where the majority of microbiota reside  ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: CRISPR-NSID: an in vivo CRISPR/Cas9 negative selection screen reveals EZH2 as a druggable dependency factor in a genetic desmoid tumor model</h4><p><a href="https://www.biorxiv.org/content/10.1101/595769v1">Link</a></p><p><b>Date:</b> 2019-04-01</p><p><b>Authors:</b> Thomas Naert ... Kris Vleminckx</p><p><b>Downloads:</b> 409</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Identification of true dependencies in cancer is pivotal to the elucidation of novel therapeutic strategies to increase prospects for cancer patients.  Unfortunately, in vivo identification of genetic dependencies has long relied on expensive and time-consuming breeding of genetically engineered animal models.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Haplotyping by CRISPR-mediated DNA circularization (CRISPR-hapC) broadens allele-specific gene editing.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31943080">Link</a></p><p><b>Date:</b> 01/16/2020</p><p><b>Authors:</b> Jiaying Yu ...  Lin Lin</p><p><b>Journal:</b> Nucleic Acids Res.</p><p><b>IF (7 or above):</b> 11.14</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Allele-specific protospacer adjacent motif (asPAM)-positioning SNPs and CRISPRs are valuable resources for gene therapy of dominant disorders.  However, one technical hurdle is to identify the haplotype comprising the disease-causing allele and the distal asPAM SNPs.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: In vivo measurements reveal a single 5â² intron is sufficient to increase protein expression level in C. elegans</h4><p><a href="https://www.biorxiv.org/content/10.1101/499459v1">Link</a></p><p><b>Date:</b> 2018-12-17</p><p><b>Authors:</b> Matthew M. Crane ... Alex Mendenhall</p><p><b>Downloads:</b> 387</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Introns can increase gene expression levels using a variety of mechanisms collectively referred to as Intron Mediated Enhancement (IME).  To date, the magnitude of IME has been quantified in human cell culture and plant models by comparing intronless reporter gene expression levels to those of intron-bearing reporter genes in vitro (mRNA, Western Blots, protein activity), using genome editing technologies that lacked full control of locus and copy number.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31799598">Link</a></p><p><b>Date:</b> 12/04/2019</p><p><b>Authors:</b> Bin Liu ...  Hidde J Haisma</p><p><b>Journal:</b> Nucleic Acids Res.</p><p><b>IF (7 or above):</b> 11.14</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Despite the rapid development of CRISPR/Cas9-mediated gene editing technology, the gene editing potential of CRISPR/Cas9 is hampered by low efficiency, especially for clinical applications.  One of the major challenges is that chromatin compaction inevitably limits the Cas9 protein access to the tar ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Sort-purification of human CD34+CD90+ cells reduces target cell population and improves lentiviral transduction for gene therapy</h4><p><a href="https://www.biorxiv.org/content/10.1101/850479v2">Link</a></p><p><b>Date:</b> 2019-11-26</p><p><b>Authors:</b> Stefan Radtke ... Hans-Peter Kiem</p><p><b>Downloads:</b> 265</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Hematopoietic stem cell (HSC) gene therapy has the potential to cure many genetic, malignant and infectious diseases.  We have shown in a nonhuman primate (NHP) HSC gene therapy and transplantation model that the CD34+CD90+ cell fraction was exclusively responsible for multilineage engraftment and hematopoietic reconstitution.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: DNA targeting by Clostridium cellulolyticum CRISPR-Cas9 Type II-C system.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31943070">Link</a></p><p><b>Date:</b> 01/16/2020</p><p><b>Authors:</b> Iana Fedorova ...  Konstantin Severinov</p><p><b>Journal:</b> Nucleic Acids Res.</p><p><b>IF (7 or above):</b> 11.14</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Type II CRISPR-Cas9 RNA-guided nucleases are widely used for genome engineering.  Type II-A SpCas9 protein from Streptococcus pyogenes is the most investigated and highly used enzyme of its class.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Mono-homologous linear DNA recombination by the non-homologous end-joining pathway as a novel and simple gene inactivation method: a proof of concept study in Dietzia sp. DQ12-45-1b</h4><p><a href="https://www.biorxiv.org/content/10.1101/300723v1">Link</a></p><p><b>Date:</b> 2018-04-13</p><p><b>Authors:</b> Shelian Lu ... Xiao-Lei Wu</p><p><b>Downloads:</b> 229</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Non-homologous end-joining (NHEJ) is critical for genome stability because of its roles in double-strand break repair.  Ku and ligase D (LigD) are the crucial proteins in this process, and strains expressing Ku and LigD can cyclize linear DNA in vivo.</p></div></td></div><td></td></tr></table></div><hr></div></body></html>